Company Filing History:
1 out of 1,575 
1 out of 549 
1 out of 321 
Years Active: 2016-2022
Title: Byoung Sik Kim: Innovator in Antibacterial Research
Introduction
Byoung Sik Kim is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of antibacterial research, holding 2 patents that focus on innovative methods for treating infections.
Latest Patents
His latest patents include the "RTX toxin production inhibitor and composition for treating symptom of vibrio infection by using same." This invention provides a method for treating symptoms of vibrio infection by utilizing an RTX toxin production inhibitor. The inhibitor comprises N-(4-oxo-4H-thieno[3,4-c]chromen-3-yl)-3-phenylprop-2-ynamide and its derivatives, which can prevent or treat symptoms of vibrio infection by inhibiting RTX toxin production. This approach aims to reduce the pathogenicity of vibrio bacteria without directly killing them, offering an alternative to traditional antibiotics that often lead to resistance.
Another significant patent is related to the "Crystal structure of the NanR and ManNAc-6P complex, and uses thereof." This invention explores the three-dimensional structure of a complex formed by NanR, a key pathogenic regulatory protein, and ManNAc-6P, a NanR regulator. The patent also discusses a modified NanR protein, a polynucleotide encoding the protein, and methods for screening substances that regulate interactions between NanR and the transcriptional control region of the nan operon.
Career Highlights
Byoung Sik Kim has worked with prestigious institutions, including Seoul National University and the Snur & Db Foundation. His research has focused on developing innovative solutions to combat bacterial infections, contributing to advancements in medical science.
Collaborations
He has collaborated with notable colleagues such as Sang Ho Choi and Lak Shin Jeong, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Byoung Sik Kim's work in antibacterial research exemplifies the importance of innovation in addressing public health challenges. His patents reflect a commitment to developing alternative treatments that can mitigate the issues of antibiotic resistance.